Such patients displayed increased galectin-9-positive tumor cells and FOXP3+ lymphocytes, whereas the TIM-3+ lymphocytes were decreased in the tumor microenvironment compared with primary NPCs, suggesting that the galectin-9–TIM-3 pathway mediates immune escape by NPCs [46]. The gene discussed is HAVCR2; the disease is neoplasm.